C07D 269/02
Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom
Official title: having the hetero atoms in positions 1 and 3
C07D269/02 (Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom) appears on 9 US grants and 10 published applications in this corpus.
Search patents in C07D- Granted patents
- 9
- Published applications
- 10
- Assignees
- 7
- Inventors
- 26
- Latest grant
- 3 Oct 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 2 | 2 |
| 2018 | 2 | 2 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Heterocycle amines and uses thereof3 Oct 2023US 11,773,110 B2Ligand Pharmaceuticals Incorporated
- Heterocycle amines and uses thereof30 Nov 2021US 11,186,593 B2Ligand Pharmaceuticals Incorporated
- Heterocycle amines and uses thereof31 Mar 2020US 10,604,533 B2Ligand Pharmaceuticals Incorporated
- Heterocycle amines and uses thereof24 Jul 2018US 10,030,034 B2Ligand Pharmaceuticals Incorporated
- Piperazine derivatives for treating disorders3 Apr 2018US 9,932,330 B2NewSouth Innovations Pty Limited
- Arylamine organic compound and use thereof20 Jun 2024US 2024/0199559 A1Guangzhou Chinaray Optoelectronic Materials Ltd.
- Heterocycle amines and uses thereof21 Apr 2022US 2022/0119413 A1Ligand Pharmaceuticals Incorporated
- Heterocycle amines and uses thereof9 Jul 2020US 2020/0216468 A1Ligand Pharmaceuticals Incorporated
- Heterocycle amines and uses thereof18 Oct 2018US 2018/0298031 A1Ligand Pharmaceuticals Incorporated
- Piperazine derivatives for treating disorders15 Feb 2018US 2018/0044331 A1NewSouth Innovations Pty Limited
Most cited
By later US patents
- Heterocycle amines and uses thereof5US 10,030,034 B2Ligand Pharmaceuticals Incorporated · 2018
- Sonic hedgehog modulators2US 8,530,456 B2Massachusetts Institute of Technology · 2013
- Heterocycle amines and uses thereof2US 9,266,874 B2Ligand Pharmaceuticals Incorporated · 2016
- Heterocycle amines and uses thereof1US 10,604,533 B2Ligand Pharmaceuticals Incorporated · 2020
- Heterocycle amines and uses thereof1US 11,186,593 B2Ligand Pharmaceuticals Incorporated · 2021